Literature DB >> 11678915

Screening of a HUVEC cDNA library with transplant-associated coronary artery disease sera identifies RPL7 as a candidate autoantigen associated with this disease.

A T Linke1, B Marchant, P Marsh, G Frampton, J Murphy, M L Rose.   

Abstract

A HUVEC cDNA library was screened with sera from two patients who had developed transplant-associated coronary artery disease (TxCAD) following cardiac transplantation. A total of six positive clones were isolated from a primary screen of 40 000 genes. Subsequent DNA sequence analysis identified these to be lysyl tRNA synthetase, ribosomal protein L7, ribosomal protein L9, beta transducin and TANK. Another gene whose product could not be identified showed homology to a human cDNA clone (DKFZp566M063) derived from fetal kidney. Full-length constructs of selected genes were expressed as his-tag recombinant fusion proteins and used to screen a wider patient base by ELISA to determine prevalence and association with TxCAD. Of these ribosomal protein L7 showed the highest prevalence (55.6%) with TxCAD sera compared to 10% non-CAD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11678915      PMCID: PMC1906172          DOI: 10.1046/j.1365-2249.2001.01654.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Characterization of endothelial antigens associated with transplant-associated coronary artery disease.

Authors:  C H Wheeler; A Collins; M J Dunn; S J Crisp; M H Yacoub; M L Rose
Journal:  J Heart Lung Transplant       Date:  1995 Nov-Dec       Impact factor: 10.247

2.  Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.

Authors:  M Rabinovitch; S Molossi; N Clausell
Journal:  J Heart Lung Transplant       Date:  1995 Nov-Dec       Impact factor: 10.247

3.  Vascular smooth muscle cells and neointimal hyperplasia in chronic transplant rejection.

Authors:  J G Geraghty; R L Stoltenberg; H W Sollinger; D A Hullett
Journal:  Transplantation       Date:  1996-08-27       Impact factor: 4.939

4.  Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching.

Authors:  J D Smith; M L Rose; A Pomerance; M Burke; M H Yacoub
Journal:  Lancet       Date:  1995-11-18       Impact factor: 79.321

Review 5.  Immunopathology of cardiac transplant rejection.

Authors:  R J Duquesnoy; A J Demetris
Journal:  Curr Opin Cardiol       Date:  1995-03       Impact factor: 2.161

6.  Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease?

Authors:  S J Crisp; M J Dunn; M L Rose; M Barbir; M H Yacoub
Journal:  J Heart Lung Transplant       Date:  1994 Jan-Feb       Impact factor: 10.247

7.  Antibody to CD18 reduces neutrophil and T lymphocyte infiltration and vascular cell adhesion molecule-1 expression in cardiac rejection.

Authors:  H Akimoto; T O McDonald; J T Weyhrich; R Thomas; C L Rothnie; M D Allen
Journal:  Transplantation       Date:  1996-06-15       Impact factor: 4.939

8.  Structural organization and chromosomal localization of the human ribosomal protein L9 gene.

Authors:  K Mazuruk; T J Schoen; G J Chader; T Iwata; I R Rodriguez
Journal:  Biochim Biophys Acta       Date:  1996-03-01

9.  Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease.

Authors:  E F Reed; B Hong; E Ho; P E Harris; J Weinberger; N Suciu-Foca
Journal:  Transplantation       Date:  1996-02-27       Impact factor: 4.939

10.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.

Authors:  L A Casciola-Rosen; G Anhalt; A Rosen
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  15 in total

1.  Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses.

Authors:  Fabrice Porcheray; Julie DeVito; Beow Y Yeap; Lijuan Xue; Ian Dargon; Rosemary Paine; Timothy C Girouard; Susan L Saidman; Robert B Colvin; Waichi Wong; Emmanuel Zorn
Journal:  Transplantation       Date:  2010-05-27       Impact factor: 4.939

2.  Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.

Authors:  Dilip S Nath; Haseeb Ilias Basha; Venkataswarup Tiriveedhi; Chiraag Alur; Donna Phelan; Gregory A Ewald; Nader Moazami; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2010-07-07       Impact factor: 10.247

3.  Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response.

Authors:  Sang Gyu Park; Hye Jin Kim; You Hong Min; Eung-Chil Choi; Young Kee Shin; Bum-Joon Park; Sang Won Lee; Sunghoon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

4.  Expansion of polyreactive B cells cross-reactive to HLA and self in the blood of a patient with kidney graft rejection.

Authors:  F Porcheray; J DeVito; Y Helou; I Dargon; J W Fraser; P Nobecourt; J Ferdman; S Germana; T C Girouard; T Kawai; S L Saidman; W Wong; R B Colvin; C Leguern; E Zorn
Journal:  Am J Transplant       Date:  2012-04-17       Impact factor: 8.086

5.  Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss.

Authors:  B Gao; C Moore; F Porcheray; C Rong; C Abidoglu; J DeVito; R Paine; T C Girouard; S L Saidman; D Schoenfeld; B Levin; W Wong; N Elias; C Schuetz; I Rosales; Y Fu; E Zorn
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

6.  Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Methods Mol Biol       Date:  2013

7.  Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

Authors:  Balakrishnan Mahesh; Hon-Sing Leong; Ann McCormack; Padmini Sarathchandra; Angela Holder; Marlene L Rose
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

8.  Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement.

Authors:  F Porcheray; J W Fraser; B Gao; A McColl; J DeVito; I Dargon; Y Helou; W Wong; T C Girouard; S L Saidman; R B Colvin; A Palmisano; U Maggiore; A Vaglio; R N Smith; E Zorn
Journal:  Am J Transplant       Date:  2013-08-06       Impact factor: 8.086

9.  Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX).

Authors:  Toshio Machida; Motoo Kubota; Eiichi Kobayashi; Yasuo Iwadate; Naokatsu Saeki; Akira Yamaura; Fumio Nomura; Masaki Takiguchi; Takaki Hiwasa
Journal:  J Transl Med       Date:  2015-02-22       Impact factor: 5.531

10.  Sp1-Mediated circRNA circHipk2 Regulates Myogenesis by Targeting Ribosomal Protein Rpl7.

Authors:  Junyu Yan; Yalan Yang; Xinhao Fan; Yijie Tang; Zhonglin Tang
Journal:  Genes (Basel)       Date:  2021-05-08       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.